Last Updated: August 27, 2026

FEXOFENADINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fexofenadine, and what generic alternatives are available?

Fexofenadine is a drug marketed by Barr, Aurobindo Pharma Ltd, P And L, Contract Pharmacal, Dr Reddys Labs Ltd, L Perrigo Co, Rising, Teva, Granules, Hetero Labs Ltd V, Sciegen Pharms, Sun Pharm Inds, Time Cap Labs, Unique, Aurobindo Pharma, Dr Reddys, Impax Pharms, and Sun Pharm. and is included in twenty-five NDAs.

The generic ingredient in FEXOFENADINE is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for FEXOFENADINE?
  • What are the global sales for FEXOFENADINE?
  • What is Average Wholesale Price for FEXOFENADINE?
Summary for FEXOFENADINE
US Patents:0
Applicants:18
NDAs:25
Drug Prices: Drug price information for FEXOFENADINE
Drug Sales Revenues: Drug sales revenues for FEXOFENADINE
DailyMed Link:FEXOFENADINE at DailyMed
Drug patent expirations by year for FEXOFENADINE
Drug Prices for FEXOFENADINE

See drug prices for FEXOFENADINE

Drug Sales Revenue Trends for FEXOFENADINE

See drug sales revenues for FEXOFENADINE

US Patents and Regulatory Information for FEXOFENADINE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 076236-001 Apr 14, 2005 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 091567-004 Feb 6, 2012 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 076502-009 Apr 12, 2011 OTC No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Impax Pharms FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 076298-001 Nov 12, 2010 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rising FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 077081-007 Jul 21, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 091567-005 Feb 6, 2012 OTC No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for FEXOFENADINE
Which of the below is the pl generic brand of fexofenadine hcl ? *
Fexofenadine and atorvastatin interaction?
Which of the below is the pl generic brand of fexofenadine hcl ? * allegra 120mg histafree 120mg histakem 120mg ondem 120mg
Fexofenadine 180mg tablets (otc)?
Fexofenadine hydrochloride patent?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links